Evidence map›Paper›PMID 42568590›Full record

ArticleFrontiers in cell and developmental biology2026

VEA-net: vascular enhancement attention with dual-backbone multi-task learning for comprehensive ROP management across multi-center datasets.

Yuan Chen, Jiajun Wan, Tian Zhang, Zhijiang Wan, Jin Hong, Youpeng Jin

Abstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yuan ChenDepartment of Pediatrics, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Jiajun WanCollege for Excellent Engineers, Nanchang University, Nanchang, Jiangxi, China.
Tian ZhangDepartment of Pediatrics, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Zhijiang WanCollege for Excellent Engineers, Nanchang University, Nanchang, Jiangxi, China.
Jin HongSchool of Artificial Intelligence, Nanchang University, Nanchang, Jiangxi, China.
Youpeng JinDepartment of Pediatrics, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Retinopathy of Prematurity (ROP) is a vasoproliferative retinal disorder and a major cause of childhood blindness worldwide. Clinical ROP management involves three correlated tasks: Plus disease detection, stage classification, and treatment decision-making. Although deep learning (DL) has shown promise for automated ROP management, several challenges remain: (1) retinal vascular morphology is central to Plus disease assessment, but DL-based vascular feature modeling is not always explicitly integrated into unified end-to-end multi-task frameworks; (2) Plus disease detection, stage classification, and treatment decision-making are clinically related, yet they are often modeled as separate tasks; and (3) model robustness may be affected by class imbalance and domain shifts across heterogeneous datasets. Methods: We propose VEA-Net, a novel dual-backbone multi-task learning framework that addresses these challenges through three core components: (1) We introduce the Vascular Enhancement Attention (VEA) module, which explicitly models and enhances vascular features through multi-scale convolutions, directional selective filtering, and dual attention mechanisms. (2) We develop a hierarchical multi-task learning architecture that jointly optimizes Plus detection, stage classification, and treatment decision-making while leveraging task correlations through hierarchical consistency losses. (3) We implement a dual-domain adaptation strategy combining Domain-Adversarial Neural Networks (DANN) with Maximum Mean Discrepancy (MMD) to learn domain-invariant representations across heterogeneous data sources. Results: We validate VEA-Net on three public ROP datasets (FARFUM-ROP, Ostrava, and A-Fundus), comprising 8,636 retinal images from different geographic regions and imaging settings. Using subject-level 10-fold cross-validation with Group K-Fold splitting, our model achieves test AUROC of 91.76% Conclusion: VEA-Net provides a unified framework for image-based ROP management by integrating vascular enhancement, hierarchical multi-task learning, and domain adaptation. The model supports Plus detection, stage classification, and auxiliary treatment decision support within a single architecture. The results indicate VEA-Net can learn robust representations across heterogeneous public datasets, and potential for improving ROP management efficiency.

Indexed as

computer-aided diagnosisconvolutional neural networksdeep learningdomain adaptationmulti-task learningretinopathy of prematuritytreatment decision supportvascular enhancement

Identifiers

PMID42568590
PMCPMC13447418

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.